|
Novartis Increases Stake in Alnylam
|
Wade Roush |
05/08/08 |
|
No Comments
|
|
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News
|
Rebecca Zacks |
05/07/08 |
|
No Comments
|
|
Let the Epic Curing Begin: Epix and Curis Earn Milestone Payments
|
Erik Mellgren |
05/05/08 |
|
No Comments
|
|
Mascoma Teams with GM, Moldflow Melds with Autodesk, Concert Scores Some Heavy-Duty Cash, & More Deals News
|
Rebecca Zacks |
05/05/08 |
|
No Comments
|
|
Three Luminaries, Two Third Revolutions, and One Nice Suit: An Xconomy Forum on the Future of Life Sciences in New England
|
Rebecca Zacks |
05/02/08 |
|
No Comments
|
|
GM Chips In for Mascoma’s Cellulosic Biofuel Technology
|
Wade Roush |
05/02/08 |
|
No Comments
|
|
Take Two Blueberry Jelly Beans and Call Me in the Morning: Cambridge Biotech’s Best and Brightest on Show (or Not)
|
Erik Mellgren |
05/02/08 |
|
1 Comment
|
|
Heavyweight Hydrogen Takes $37 Million Prize for Concert Pharmaceuticals
|
Erik Mellgren |
05/01/08 |
|
No Comments
|
|
InfraReDx Gets FDA Nod for Artery-Imaging Tool
|
Rebecca Zacks |
04/30/08 |
|
No Comments
|
|
ZS Genetics Enters the X Prize Fray, Biogen Falls on Rituxan News, Acusphere Takes a Step Toward Clinical Finish Line, & More Life Sciences News
|
Rebecca Zacks |
04/30/08 |
|
No Comments
|
|
Retail Convergence Meets Up With Some Cash, TheStreet Takes to Geezeo, GSK Lifts a Glass to Sirtris, & More Deals News
|
Rebecca Zacks |
04/28/08 |
|
No Comments
|
|
Startup Seals Deal With MIT on Wound-Sealing, Self-Assembling, Nanoscale Technology
|
Rebecca Zacks |
04/25/08 |
|
No Comments
|
|
Top First Quarter New England Venture Investments
|
Robert Buderi |
04/23/08 |
|
No Comments
|
|
Sirtris Exec Says Acquisition by GlaxoSmithKline is “Great for Boston”
|
Wade Roush |
04/22/08 |
|
1 Comment
|
|
GlaxoSmithKline Scoops Up Sirtris
|
Wade Roush |
04/22/08 |
|
2 Comments
|
|
Resolvyx gets $25 Million in Financing to Turn Fish-Oil Science into New Drugs
|
Erik Mellgren |
04/22/08 |
|
No Comments
|
|
Cambria Pharmaceuticals Reaps $5.4M Financing
|
Erik Mellgren |
04/22/08 |
|
No Comments
|
|
FDA Decision a Blow For Genzyme—and Biogenerics?
|
Rebecca Zacks |
04/22/08 |
|
1 Comment
|
|
With New Machine, Helicos Brings Personal Genome Sequencing A Step Closer
|
Erik Mellgren |
04/22/08 |
|
No Comments
|
|
New England Venture Investment Falls Sharply in Q1—But Exactly How Far Is the Question
|
Robert Buderi |
04/21/08 |
|
No Comments
|
|
With a $25 Million Bankroll and Technology “Fully Baked” by Biogen Idec, Stromedix is Heading into the Uncharted Territory of Fibrosis
|
Rebecca Zacks |
04/21/08 |
|
No Comments
|
|
Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million
|
Erik Mellgren |
04/17/08 |
|
No Comments
|
|
Biogen Idec Announces Its Own Director Slate—Digs in Against Icahn
|
Robert Buderi |
04/17/08 |
|
No Comments
|
|
Dynogen, Apex Call Off Reverse Merger
|
Rebecca Zacks |
04/17/08 |
|
No Comments
|
|
$50 Million Serono Expansion to Create 100 New Massachusetts Jobs
|
Erik Mellgren |
04/16/08 |
|
No Comments
|
|
Codon Devices to Engineer Protein Drug for Merrimack Pharmaceuticals
|
Erik Mellgren |
04/16/08 |
|
No Comments
|
|
Aileron Raises $10 Million
|
Robert Buderi |
04/15/08 |
|
No Comments
|
|
ArQule Gets a New CEO
|
Wade Roush |
04/15/08 |
|
No Comments
|
|
Entrepreneurs at Three Massachusetts Colleges Rake in the Prize Money
|
Rebecca Zacks |
04/15/08 |
|
2 Comments
|
|
Life Sciences 2028—Three Snapshots of the Future
|
Robert Buderi |
04/14/08 |
|
No Comments
|
